We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
-11.47%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$2.53B
AUM Growth
-$2.14B
Cap. Flow
-$1.75B
Cap. Flow %
-69.35%
Top 10 Hldgs %
49.71%
Holding
356
New
76
Increased
34
Reduced
55
Closed
123

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.94%
2 Financials 8.47%
3 Industrials 6.21%
4 Communication Services 5.42%
5 Technology 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTMX icon
151
CytomX Therapeutics
CTMX
$701M
$1.89M 0.07%
125,000
IMMU
152
DELISTED
Immunomedics Inc
IMMU
$1.84M 0.07%
+129,041
New +$2.56M
PE
153
DELISTED
PARSLEY ENERGY INC
PE
$1.84M 0.07%
115,000
-120,000
-51% -$2.73M
CZR
154
DELISTED
Caesars Entertainment Corporation
CZR
$1.7M 0.07%
+250,000
New +$2.11M
MRO
155
DELISTED
Marathon Oil Corporation
MRO
$1.65M 0.07%
115,000
-160,000
-58% -$2.86M
GLNG icon
156
Golar LNG
GLNG
$4.95B
$1.63M 0.06%
+75,000
New +$1.94M
TECK icon
157
Teck Resources
TECK
$28.8B
$1.62M 0.06%
75,000
-75,000
-50% -$1.63M
GWPH
158
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.46M 0.06%
15,000
-5,000
-25% -$656K
WPX
159
DELISTED
WPX Energy, Inc.
WPX
$1.42M 0.06%
+125,000
New +$1.9M
XEC
160
DELISTED
CIMAREX ENERGY CO
XEC
$1.42M 0.06%
23,000
+10,000
+77% +$821K
SRPT icon
161
Sarepta Therapeutics
SRPT
$1.63B
$1.37M 0.05%
12,553
+7,553
+151% +$945K
IOVA icon
162
Iovance Biotherapeutics
IOVA
$2.1B
$1.33M 0.05%
150,000
+25,000
+20% +$241K
KRP icon
163
Kimbell Royalty Partners
KRP
$1.43B
$1.26M 0.05%
93,000
-7,000
-7% -$124K
VRAY
164
DELISTED
ViewRay, Inc.
VRAY
$1.21M 0.05%
200,000
+50,000
+33% +$375K
NFX
165
DELISTED
Newfield Exploration
NFX
$1.17M 0.05%
80,000
+5,000
+7% +$101K
BOC icon
166
Boston Omaha
BOC
$435M
$1.17M 0.05%
50,000
-15,000
-23% -$391K
ZGNX
167
DELISTED
Zogenix, Inc.
ZGNX
$1.09M 0.04%
30,000
NERV icon
168
Minerva Neurosciences
NERV
$199M
$1.01M 0.04%
18,750
-4,075
-18% -$298K
MCF
169
DELISTED
Contango Oil & Gas Co.
MCF
$975K 0.04%
+300,000
New +$1.39M
KPTI icon
170
Karyopharm Therapeutics
KPTI
$161M
$937K 0.04%
6,667
AZRE
171
DELISTED
Azure Power Global Limited
AZRE
$905K 0.04%
+100,000
New +$1.11M
LGF.A
172
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$789K 0.03%
49,021
-200,000
-80% -$3.87M
SVRA icon
173
Savara
SVRA
$1.09B
$757K 0.03%
100,000
FE icon
174
FirstEnergy
FE
$28.7B
$751K 0.03%
20,000
-30,000
-60% -$1.14M
GNMK
175
DELISTED
GenMark Diagnostics, Inc
GNMK
$729K 0.03%
+150,000
New +$781K

Similar funds

Moore Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Moore Capital Management held 356 positions worth $2.53B, down 46% from $4.66B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Moore Capital Management withdrew a net $1.75B in Q4 2018, closing 123 positions and reducing 55 holdings. Its most notable exit was First Data Corporation, an estimated $91.2M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Moore Capital Management opened a new position in iShares Core S&P 500 ETF worth $365M.

  • Moore Capital Management's largest Q4 2018 buy was iShares Core S&P 500 ETF: 1,452,614 shares worth $365M.
  • Moore Capital Management added most to VanEck Gold Miners ETF in Q4 2018, an estimated $95.5M increase.
  • Moore Capital Management's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $47.9M.
  • Moore Capital Management fully exited First Data Corporation in Q4 2018, selling an estimated $91.2M.
  • Moore Capital Management's ten largest holdings make up 50% of its $2.53B portfolio in Q4 2018.
  • Moore Capital Management opened 76 new positions and closed 123 in Q4 2018.
  • Moore Capital Management's portfolio value fell 46% quarter-over-quarter to $2.53B.

Based on Moore Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.